This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

Leahy demands Myriad “march-in rights”


Leahy demands Myriad “march-in rights”

Senator Patrick Leahy has urged the US National Institutes of Health (NIH) to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer.

myriad genetics, senator patrick leahy, march-in rights, Bayh-Doyle Act, brca1, brca2


Payment types accepted